Related Experiment Video
Updated: Jan 12, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
Ulcerative colitis: moving beyond the mucosal dogma.
Elisabeth Eggermont1, Krisztina Gecse2, Noa Krugliak Cleveland3
1Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium; Department of Chronic Diseases and Metabolism, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Ulcerative colitis involves deeper bowel layers, not just the mucosa. These transmural changes, seen via intestinal ultrasound, may explain persistent symptoms and impact future ulcerative colitis treatment strategies.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Medical Imaging
Background:
- Ulcerative colitis (UC) traditionally viewed as mucosal disease.
- Crohn's disease (CD) characterized by transmural inflammation and fibrosis.
- Emerging evidence suggests UC also involves deeper bowel layers.
Purpose of the Study:
- Summarize evidence of transmural changes in UC.
- Highlight sonographic, macroscopic, and histopathological findings.
- Discuss implications for UC understanding and treatment.
Main Methods:
- Review of existing sonographic, macroscopic, and histopathological data.
- Intestinal ultrasound for in-vivo characterization of bowel wall.
- Analysis of macroscopic and histological findings.
Main Results:
- UC shows transmural alterations: increased bowel wall thickness, submucosal thickening, loss of stratification, haustral loss, mesenteric fibrofatty proliferation.
- Deeper changes like colonic shortening, fibrotic strictures, and muscular remodelling observed.
- Submucosal thickening may persist even in endoscopic remission.
Conclusions:
- UC extends beyond the mucosa, exhibiting transmural changes.
- These changes may contribute to persistent functional bowel symptoms.
- Recognizing UC as a progressive transmural disease may inform future therapeutic targets.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

